Otrexup FDA Approval History
FDA Approved: Yes (First approved October 11, 2013)
Brand name: Otrexup
Generic name: methotrexate
Dosage form: Subcutaneous Injection
Company: Antares Pharma, Inc.
Treatment for: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis, Psoriasis
Otrexup (methotrexate) is a folate analog metabolic inhibitor self-administered once weekly for use in the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis and psoriasis.
Development timeline for Otrexup
| Date | Article |
|---|---|
| Oct 15, 2013 | Approval Otrexup (Methotrexate) Injection Approved By FDA |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
